FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Indrayani Biotech standalone net profit rises 1485.71% in the March 2025 quarter
(13-Jun-2025, 09:19 Hours IST)  
Net profit of Indrayani Biotech rose 1485.71% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 0.07 crore during the previous quarter ended March 2024. Sales declined 41.27% to Rs 9.28 crore in the quarter ended March 2025 as against Rs 15.80 crore during the previous quarter ended March 2024.

For the full year,net profit declined 0.68% to Rs 1.45 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 39.39% to Rs 37.77 crore in the year ended March 2025 as against Rs 62.32 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales9.2815.80 -41 37.7762.32 -39
OPM %18.536.27 -14.489.10 -
PBDT0.261.97 -87 1.674.46 -63
PBT0.201.62 -88 0.653.01 -78
NP1.110.07 1486 1.451.46 -1

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)